Literature DB >> 25701550

Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins.

Eileen Chen1, Simpson Joseph2.   

Abstract

Translational control is a common mechanism used to regulate gene expression and occur in bacteria to mammals. Typically in translational control, an RNA-binding protein binds to a unique sequence in the mRNA to regulate protein synthesis by the ribosomes. Alternatively, a protein may bind to or modify a translation factor to globally regulate protein synthesis by the cell. Here, we review translational control by the fragile X mental retardation protein (FMRP), the absence of which causes the neurological disease, fragile X syndrome (FXS).
Copyright © 2015 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Fragile X mental retardation protein; Fragile X syndrome; Neuron; RNA; Ribosome; Translation

Mesh:

Substances:

Year:  2015        PMID: 25701550      PMCID: PMC4458461          DOI: 10.1016/j.biochi.2015.02.005

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  100 in total

1.  Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

Authors:  S L Sherman
Journal:  Am J Hum Genet       Date:  2000-06-12       Impact factor: 11.025

Review 2.  A mechanistic overview of translation initiation in eukaryotes.

Authors:  Colin Echeverría Aitken; Jon R Lorsch
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

Review 3.  Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond.

Authors:  Aaron W Grossman; Georgina M Aldridge; Ivan Jeanne Weiler; William T Greenough
Journal:  J Neurosci       Date:  2006-07-05       Impact factor: 6.167

4.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  The fragile X mental retardation protein is associated with ribosomes.

Authors:  E W Khandjian; F Corbin; S Woerly; F Rousseau
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

6.  Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein.

Authors:  L Wan; T C Dockendorff; T A Jongens; G Dreyfuss
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

7.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

8.  Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Authors:  Dilek Colak; Nikica Zaninovic; Michael S Cohen; Zev Rosenwaks; Wang-Yong Yang; Jeannine Gerhardt; Matthew D Disney; Samie R Jaffrey
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

9.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

10.  Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

Authors:  Jing Zhang; Lingfei Hou; Eric Klann; David L Nelson
Journal:  J Neurophysiol       Date:  2009-02-25       Impact factor: 2.714

View more
  28 in total

Review 1.  Cardinal Epigenetic Role of non-coding Regulatory RNAs in Circadian Rhythm.

Authors:  Utpal Bhadra; Pradipta Patra; Manika Pal-Bhadra
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

2.  Human DDX21 binds and unwinds RNA guanine quadruplexes.

Authors:  Ewan K S McRae; Evan P Booy; Aniel Moya-Torres; Peyman Ezzati; Jörg Stetefeld; Sean A McKenna
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

3.  Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome.

Authors:  Risa Kashima; Sougata Roy; Manuel Ascano; Veronica Martinez-Cerdeno; Jeanelle Ariza-Torres; Sunghwan Kim; Justin Louie; Yao Lu; Patricio Leyton; Kenneth D Bloch; Thomas B Kornberg; Paul J Hagerman; Randi Hagerman; Giorgio Lagna; Akiko Hata
Journal:  Sci Signal       Date:  2016-06-07       Impact factor: 8.192

4.  Finding FMR1 mosaicism in Fragile X syndrome.

Authors:  Thaís Fernandez Gonçalves; Jussara Mendonça dos Santos; Andressa Pereira Gonçalves; Flora Tassone; Guadalupe Mendoza-Morales; Márcia Gonçalves Ribeiro; Evelyn Kahn; Raquel Boy; Márcia Mattos Gonçalves Pimentel; Cíntia Barros Santos-Rebouças
Journal:  Expert Rev Mol Diagn       Date:  2016-02-09       Impact factor: 5.225

Review 5.  Cas6 processes tight and relaxed repeat RNA via multiple mechanisms: A hypothesis.

Authors:  Jana Sefcikova; Mitchell Roth; Ge Yu; Hong Li
Journal:  Bioessays       Date:  2017-05-11       Impact factor: 4.345

Review 6.  RNA-binding proteins in human genetic disease.

Authors:  Fátima Gebauer; Thomas Schwarzl; Juan Valcárcel; Matthias W Hentze
Journal:  Nat Rev Genet       Date:  2020-11-24       Impact factor: 53.242

Review 7.  Behavioral phenotypes of genetic mouse models of autism.

Authors:  T M Kazdoba; P T Leach; J N Crawley
Journal:  Genes Brain Behav       Date:  2015-10-22       Impact factor: 3.449

Review 8.  Protein Translation and Psychiatric Disorders.

Authors:  Sophie Laguesse; Dorit Ron
Journal:  Neuroscientist       Date:  2019-07-04       Impact factor: 7.519

9.  FMRP Mediates Chronic Ethanol-Induced Changes in NMDA, Kv4.2, and KChIP3 Expression in the Hippocampus.

Authors:  Kathryn B Spencer; Patrick J Mulholland; L Judson Chandler
Journal:  Alcohol Clin Exp Res       Date:  2016-05-05       Impact factor: 3.455

Review 10.  Dosage effects of human ribosomal genes (rDNA) in health and disease.

Authors:  L N Porokhovnik; N A Lyapunova
Journal:  Chromosome Res       Date:  2018-10-20       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.